fashion -WSS

fashion

author：entertainment 2025-09-03 03:43:17 - browse：27

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The future of health care in the House

WSS

Bill would stop addiction treatment from triggering child abuse inquiry

Three trends to watch in biotech in 2024

AI can decode, harness the power of the humane immune system

Was Amgen transparent enough on FDA's concern on cancer drug?

CRISPR gene editing developments we’re watching in 2024

Liquid biopsy for lung cancer is launched by Delfi

hotspot

fashion

focus

Peter Hotez and the public health issue of online harassment

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

How one medical school became remarkably diverse

Why age limits for politicians are a terrible idea

Alkermes shareholders re

Christmas in the PICU brings some surprising joy

Heart attack and stroke risk calculators need revising

Sana to lay off nearly a third of staff, de

DIEP, the 'gold standard' of breast reconstruction, is under threat

3 questions for the future of Biden's cancer moonshot

hotspot

VC firm General Catalyst wants to buy a health system

VC firm General Catalyst wants to buy a health system

A Q&A with the global head of Boehringer Ingelheim's innovation unit

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Histogen: Failed biotech offers rare public look inside

3 questions for the future of Biden's cancer moonshot

focus

knowledge

explore

knowledge